Johnson & Johnson to Participate in the Citi's 2025 Global Healthcare Conference

Johnson & Johnson to Participate in the Citi's 2025 Global Healthcare Conference

Johnson & Johnson (NYSE: JNJ) will present at the Citi's 2025 Global Healthcare Conference on Wednesday, December 3 rd , 2025. Management will participate in a Fireside Chat at 11:15 a.m. Eastern Time.

A live audio webcast of the presentation will be accessible through Johnson & Johnson's Investor Relations website at www.investor.jnj.com . An archived edition of the session will be available later that day.

The audio webcast replay will be available approximately 48 hours after the webcast.

Media contact:
media-relations@its.jnj.com

Investor contact:
investor-relations@its.jnj.com

News Provided by Business Wire via QuoteMedia

Johnson & JohnsonJNJNYSE:JNJ
JNJ
The Conversation (0)
doctor with hands together, palms up below digital medical symbols

Innovations and Opportunities in European Healthcare Technologies

In recent years, European companies have emerged as trailblazers in healthcare technology, effectively changing the face of health and patient care. Through innovation, they're not only improving systems, processes and patient outcomes but also saving lives.These advanced European technologies... Keep Reading...
Johnson & Johnson to Participate in the Goldman Sachs 44th Annual Global Healthcare Conference

Johnson & Johnson to Participate in the Goldman Sachs 44th Annual Global Healthcare Conference

Johnson & Johnson (NYSE: JNJ) will participate in the Goldman Sachs 44 th Annual Global Healthcare Conference on Tuesday, June 13 th , at the Waldorf Astoria Monarch Beach Resort & Club in Dana Point, CA. Biljana Naumovic, Worldwide Vice President, Oncology, and Peter Lebowitz, Global... Keep Reading...
Johnson & Johnson and Kenvue Announce Pricing of Upsized Kenvue Inc. Initial Public Offering

Johnson & Johnson and Kenvue Announce Pricing of Upsized Kenvue Inc. Initial Public Offering

Johnson & Johnson (NYSE: JNJ) and Kenvue Inc. ("Kenvue"), a wholly owned subsidiary of Johnson & Johnson, today announced the pricing of Kenvue's upsized initial public offering ("IPO") of 172,812,560 shares of Kenvue's common stock at a price to the public of $22.00 per share. In addition,... Keep Reading...
Johnson & Johnson to Participate in the Bernstein 39th Annual Strategic Decisions Conference

Johnson & Johnson to Participate in the Bernstein 39th Annual Strategic Decisions Conference

Johnson & Johnson (NYSE: JNJ) will participate in the Bernstein 39 th Annual Strategic Decisions Conference on Wednesday, May 31 st , at the New York Hilton Midtown in New York. Joaquin Duato, Chairman of the Board and Chief Executive Officer will represent the Company in a session scheduled at... Keep Reading...

Kaleido Collaborates with Janssen on Metabolic Therapies

Kaleido Biosciences (NADAQ:KLDO) announced a research collaboration with Janssen’s World Without Disease Accelerator, part of the Janssen Pharmaceutical Companies of Johnson & Johnson (NYSE:JNJ). As quoted in the press release: The collaboration will explore the potential for Kaleido’s... Keep Reading...

Latest News

More News

Latest Press Releases

Drilling Advances at the Wagyu Gold Project

Cloncurry Gold Project Sale/Orion Merger Transaction Update

Drilling the Manindi Vanadium-Titanium-Magnetite Discovery

Altech - Service Data Confirms Exceptional Failure Rate

Related News

Battery Metals Investing

Drilling Advances at the Wagyu Gold Project

Base Metals Investing

Cloncurry Gold Project Sale/Orion Merger Transaction Update

Battery Metals Investing

Drilling the Manindi Vanadium-Titanium-Magnetite Discovery

Gold Investing

Brien Lundin: Gold, Silver Waiting for Next Leg, What's the Catalyst?

Lithium Investing

Top 5 Canadian Lithium Stocks of 2025

Battery Metals Investing

Altech - Service Data Confirms Exceptional Failure Rate

Energy Investing

Alvopetro Announces Q3 2025 Financial Results and an Operational Update Including Record October Sales